Join to View Full Profile
450 Brookline AveDana-Farber Cancer InstBoston, MA 02215
Phone+1 617-632-6855
Fax+1 617-632-5370
Dr. Meyerhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Meyerhardt is an oncologist in Boston, MA and is affiliated with Dana-Farber Cancer Institute and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 20 years. He specializes in gastrointestinal oncology.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2002
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
Yale School of MedicineClass of 1997
Certifications & Licensure
MA State Medical License 1999 - 2026
NH State Medical License 2024 - 2024
RI State Medical License 2020 - 2020
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer Start of enrollment: 2005 Jan 01
- Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer Start of enrollment: 2002 Jul 01
- Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer Start of enrollment: 2003 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials: An Ethical Imperative.Eric C Blackstone, Fabio Efficace, Jeffrey A Meyerhardt, Gregory A Abel
Journal of Clinical Oncology. 2025-04-01 - Utilizing Patient Input in Rectal Cancer Trial Design.Janet Alvarez, Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher
Journal of the National Cancer Institute. 2025-03-19 - The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance).Justin C Brown, Chao Ma, Qian Shi, Leonard B Saltz, Anthony F Shields
Cancer. 2025-03-01
Journal Articles
- Aspirin Use and Risk of Colorectal Cancer Among Older AdultsLong H Nguyen, Kimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, JAMA Oncology
- Association of Diet Quality with Survival Among People with Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 TrialKimmie Ng, Chloe Atreya, Howard S Hochster, James N Atkins, Richard M Goldberg, Charles D Blanke, Jeffrey A Meyerhardt, JAMA Network Open
- Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal CancerI-Wen Chang, Charles D Blanke, Alan P Venook, Richard M Goldberg, Jeffrey A Meyerhardt, Kimmie Ng, JAMA Oncology
Lectures
- Lessons From IDEA: Duration in Stage II and III Colon CancerASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Other
- The roles of diet, physical activity, and body weight in cancer survivorshipMeyerhardt JA, Ligibel J
http://www.uptodate.com/contents/the-roles-of-diet-physical-activity-and-body-weight-in-cancer-survi
UpToDate, Wolters Kluwer Health - 2013-04-09 - Cancer of the appendix and pseudomyxoma peritoneiMeyerhardt JA, Swanson R
http://www.uptodate.com/contents/cancer-of-the-appendix-and-pseudomyxoma-peritonei
UpToDate, Wolters Kluwer Health - 2013-03-22 - Infusion reactions to therapeutic monoclonal antibodies used for cancer therapyMeyerhardt JA, LaCasce AS, Burstein H, Castells MC
http://www.uptodate.com/contents/infusion-reactions-to-therapeutic-monoclonal-antibodies-used-for-ca
UpToDate, Wolters Kluwer Health - 2013-03-22
Authored Content
- Vitamin D Status After Colorectal Cancer Diagnosis and Patient Survival According to Immune Response to TumourOctober 2018
Press Mentions
Exercise Helps Colon Cancer Survivors Live LongerMarch 28th, 2025- Celecoxib Lowers Colon Cancer Recurrence RiskJanuary 29th, 2025
- Blood Test Identifies Advanced Colon Cancer Patients Who Benefit from CelecoxibJanuary 29th, 2025
- Join now to see all
Grant Support
- Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon CancerLSU PENNINGTON BIOMEDICAL RESEARCH CTR2022–2027
- Exercise And Metformin To Impact Hyperinsulinemia In Colorectal Cancer SurvivorsNational Cancer Institute2011
- The Influence Of Diet And Lifestyle On Patients With Advanced Colorectal CancerNational Cancer Institute2010–2011
- The Role Of Pi3-Kinase Signaling Pathway In Defining Sensitivity And ResistanceNational Cancer Institute2007–2011
- Predictors Of Outcome In Colorectal CancerNational Cancer Institute2003–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
